Metoprolol Dosage for Anxiety: What to Know About This Off-Label Use
Author:
Blossom Editorial
Metoprolol is a beta blocker approved for certain heart conditions, not for anxiety. It helps slow a racing heart and reduces some of the physical effects of adrenaline. Because of this it is sometimes prescribed off label when anxiety leads to physical symptoms.
There is no FDA-approved metoprolol dosage for anxiety, and the research on beta blockers for anxiety is limited. This guide explains what the approved dosing looks like, what studies have actually found, and where metoprolol tends to fit among anxiety treatment options.
Key Takeaways
No approved anxiety dose exists. Metoprolol is FDA approved for conditions such as high blood pressure, chest pain from angina, heart failure, and heart attack care. Because anxiety is not an approved indication, the FDA label contains no anxiety dosing guidance. Any off-label use is determined by a prescriber based on the individual.
Beta blockers mainly target physical symptoms. These medications can reduce symptoms such as a pounding heart, trembling, and shakiness. But they do not directly treat the racing thoughts, dread, or avoidance associated with anxiety disorders.
The evidence base is weak. A 2024 systematic review and meta-analysis found limited evidence supporting beta blockers for anxiety. They also suggested there is a need for better-quality research.
What Is Metoprolol and What Is It Approved to Treat?
Metoprolol is a beta blocker, meaning it blocks the effects of adrenaline at beta-adrenergic receptors. It is described as cardioselective because it acts mainly on beta-1 receptors in the heart. However, StatPearls notes that this selectivity is relative rather than absolute and can fade at higher blood levels.
Metoprolol is available in two salt forms that differ in how long they work. Metoprolol tartrate, sold as Lopressor, is an immediate release formulation that is usually taken more than once a day. Metoprolol succinate, sold as Toprol-XL, is an extended release formulation that is taken once daily.
According to the FDA prescribing information for Lopressor, the approved uses include high blood pressure, angina (chest pain), and treatment after a heart attack in adults who are medically stable. The Toprol-XL label also includes treatment of heart failure. Anxiety is not an FDA-approved indication for either formulation.
Is There an Established Metoprolol Dosage for Anxiety?
This is the question many people have, and the answer is no. Because metoprolol is not FDA approved for anxiety, there is no approved starting dose, target dose, or maximum dose for treating anxiety. Providers who prescribe it off-label for anxiety usually work from the approved dosing ranges for cardiovascular conditions and their own clinical judgment.
Approved Metoprolol Doses for Reference
The approved ranges provide some context for how metoprolol is used for heart conditions. For high blood pressure (hypertension), the Toprol-XL label describes a starting dose of 25 to 100 mg once daily, with adjustments made at weekly or longer intervals. The Lopressor label describes a usual initial dose of 100 mg daily, taken once or split into two doses, with total daily doses generally not exceeding 450 mg.
These doses are for heart conditions, not anxiety. They are included here for context only, and they should not be used as a guide for treating anxiety. Where beta blockers are used off label for situational anxiety, clinicians typically reach for doses at the low end, and sometimes on an as-needed basis, depending on the individual situations.
Why There Is No Standard Metoprolol Dose for Anxiety
Three factors can make it difficult to set a standard dose of metoprolol. First, most research on beta blockers for anxiety studied propranolol rather than metoprolol. Second, the studies that exist are usually small and use inconsistent outcome measures. Third, blood levels of metoprolol vary widely between people because it is broken down by the CYP2D6 enzyme, and people can process the medication at different rates.
The practical result is that two people taking the same dose may experience noticeably different effects on heart rate and blood pressure.
Metoprolol Tartrate vs. Metoprolol Succinate for Anxiety
When beta blockers are used for situational anxiety, the immediate-release metoprolol tartrate may be more practical than extended release form. Extended-release metoprolol succinate is designed for steady around-the-clock medication levels, which helps differently than taking something before a specific stressful event. Neither form is approved for anxiety, and the choice between them can be determined with a provider who knows your medical history, preferences, and treatment goals.
Does Metoprolol Help With Anxiety? What the Research Shows
The evidence on beta blockers for anxiety is older, sparser, and less favorable than their reputation may suggest. Most of the available research studied propranolol rather than metoprolol.
A 2016 systematic review and meta-analysis of propranolol for anxiety disorders identified only eight qualifying randomized trials. These trials covered panic disorder, specific phobia, social phobia, and Post-traumatic Stress Disorder (PTSD), with fewer than 210 participants in total. The authors suggested that the quality of evidence was insufficient to support routine use of propranolol for any anxiety disorder.
A 2024 systematic review and meta-analysis in the Journal of Affective Disorders looked more broadly at beta blockers for anxiety, The researchers found no clear evidence that beta blockers were more effective compared with placebo or benzodiazepines in social phobia or panic disorder. They also suggested that many included studies were small and at high or unclear risk of bias, and that beta blockers are increasingly prescribed for anxiety without clear evidence.
This does not prove that beta blockers cannot help with anxiety. It means the research has not been done well enough to know, and clinical practice has run ahead of the evidence.
How Beta Blockers Affect Anxiety Symptoms
Understanding how beta blockers work can help explain why some people find them useful even though trial results are mixed. Anxiety can trigger a surge of adrenaline, which produces a familiar cluster of physical symptoms. Beta blockers reduce some of these effects by blocking beta-adrenergic receptors.
Symptoms these medications may help reduce include:
Rapid or pounding heartbeat, which can make anxiety feel alarming in the moment
Trembling or shaky hands, often a common concern for performance situations
Sweating, particularly the sudden kind that can accompany acute stress
A shaky or unsteady voice, driven by the same adrenaline response
Beta blockers mainly help with physical symptoms of stress response. What they do not touch is the cognitive and emotional core of anxiety. This may include the anticipatory dread, the rumination, the avoidance. The National Institute of Mental Health (NIMH) notes that providers may sometimes prescribe beta blockers off-label for short-term anxiety symptoms, such as before a public speaking situation.
If your anxiety leads to physical symptoms, Blossom has separate guides on chest tightness from anxiety and on telling whether shortness of breath is from anxiety.
Metoprolol vs. Propranolol for Anxiety
Propranolol is the beta blocker most often associated with anxiety. It is non-selective, meaning it blocks both beta-1 and beta-2 receptors, so it can affect tremors more directly than a cardioselective medication Nearly all of the published anxiety research used propranolol, but the quality and strength of evidence remains limited.
Metoprolol was developed specifically to be more selective for beta-1 receptors in the heart and to cause fewer effects elsewhere in the body. It may have an advantage for people with cardiac conditions, but might not work well for anxiety symptoms. This is because some of the anxiety symptoms are mediated by both receptors, and metoprolol acts selectively.
This does not necessarily mean that metoprolol is useless for anxiety symptoms, or propranolol is a better alternative. It simply suggests that the choice can depend on several factors that can be determined with a licensed provider. Blossom covers propranolol in its guides on how quickly propranolol works for anxiety and when to take propranolol for anxiety.
Metoprolol Side Effects and Safety Considerations
Beta blockers such as metoprolol are generally well tolerated, but they carry specific risks that matter more when the medication is being used for an unapproved purpose.
Common Side Effects of Metoprolol
Reported side effects may include
Tiredness
Dizziness or lightheadedness
Slowed heart rate
Cold hands and feet
Headache
Gastrointestinal upset
Vivid dreams or sleep disturbance
Low mood
Depression has also been reported with metoprolol, although it is not among the most common side effects.
Who Should Avoid Metoprolol
The FDA labeling lists contraindications including cardiogenic shock and certain cases of heart failure. Metoprolol also requires caution in people with asthma or other bronchospastic conditions because it can sometimes worsen breathing problems. Medication may be avoided or used with caution in people with an already-slow heart rate, and certain heart conduction problems. Because beta blockers can mask the warning signs of low blood sugar, people with diabetes may also need additional monitoring.
Never Stop Metoprolol Abruptly
This is the most important safety point. The label warns that abrupt cessation can worsen heart-related problems such as myocardial ischemia, and may cause a rebound rise in heart rate and blood pressure.
If you and your provider decide to discontinue metoprolol, it should be tapered under supervision rather than stopped on your own.
Anxiety Treatments With Stronger Evidence
If anxiety is persistent rather than situational, treatments with more established evidence may be considered.
SSRIs and SNRIs. These antidepressants are considered first-line medication treatment for most anxiety disorders and address emotional as well as physical symptoms. They may take several weeks to reach full effect.
Cognitive behavioral therapy (CBT). This structured therapy has strong evidence for anxiety disorders and focuses on changing patterns of thinking and behavior that contribute to anxiety.
Buspirone. A non-sedating, non-habit-forming option sometimes used for generalized anxiety disorder (GAD).
Hydroxyzine. This antihistamine may be used for shorter-term anxiety relief in some situations.
Benzodiazepines. Fast acting but carrying dependence risk, so generally reserved for short-term or specific use.
Blossom has a broader overview of non-addictive anxiety medication if dependence risk is one of your concerns.
When to Talk to a Provider About Anxiety
Physical anxiety symptoms may require a proper evaluation rather than a workaround. This is partly because a racing heart can have several other causes. Similarly, thyroid problems, arrhythmias, anemia, and medication side effects can all produce similar symptoms. Blood pressure and anxiety can also affect each other, as Blossom covers in its guide on whether anxiety can cause high blood pressure.
Consider reaching out to a psychiatric provider if anxiety is interfering with work, sleep, relationships, or daily activities. It may also be worth seeking care if you are avoiding situations you used to handle or if physical symptoms are frequent enough to be disruptive.
Seek emergency care for chest pain, fainting, a very slow heartbeat, or trouble breathing. If you are in crisis, contact the 988 Suicide and Crisis Lifeline by calling or texting 988.
How Blossom Health Can Help With Anxiety Treatment
Deciding whether a beta blocker is appropriate, or another treatment may be a better fit, requires a clinician who can look at your full history and symptoms.
Blossom Health is a telehealth psychiatry platform where every provider is a licensed psychiatric clinician who can prescribe. Visits happen by video and are covered by in-network insurance, with email and text support available around the clock. If anxiety is holding you back, you can book your first appointment and connect with a provider within days. You can also check whether anxiety treatment is covered by your insurance beforehand.
Medical Disclaimer
This article is for educational purposes only and does not constitute medical advice. The information provided should not replace consultation with a qualified healthcare provider. Individual responses to medications can vary significantly, and what applies to one person may not be the same for another.
Always consult with your doctor or pharmacist before making any decisions about medication changes, discontinuation, or interactions with other substances. If you’re experiencing concerning symptoms or side effects, please seek professional help from a healthcare provider.
In case of a medical emergency, contact your local emergency services immediately or call 911. For mental health emergencies, contact the National Suicide Prevention Lifeline at 988.
Sources
U.S. Food and Drug Administration. (July, 2023). Lopressor (metoprolol tartrate) tablets: Prescribing information. accessdata.fda.gov
U.S. Food and Drug Administration. (June, 2022). Toprol-XL (metoprolol succinate) extended-release tablets: Prescribing information. accessdata.fda.gov
Morris J, Awosika AO, Dunham A. Metoprolol. [Updated 2024 Feb 29]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK532923/
Farzam K, Jan A. Beta Blockers. [Updated 2023 Aug 22]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK532906/
Archer, C., Wiles, N., Kessler, D., Turner, K., & Caldwell, D. M. (2025). Beta-blockers for the treatment of anxiety disorders: A systematic review and meta-analysis. Journal of affective disorders, 368, 90–99. https://doi.org/10.1016/j.jad.2024.09.068
Steenen, S. A., van Wijk, A. J., van der Heijden, G. J., van Westrhenen, R., de Lange, J., & de Jongh, A. (2016). Propranolol for the treatment of anxiety disorders: Systematic review and meta-analysis. Journal of psychopharmacology (Oxford, England), 30(2), 128–139. https://doi.org/10.1177/0269881115612236
Garakani, A., Murrough, J. W., Freire, R. C., Thom, R. P., Larkin, K., Buono, F. D., & Iosifescu, D. V. (2020). Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment Options. Frontiers in psychiatry, 11, 595584. https://doi.org/10.3389/fpsyt.2020.595584
National Institute of Mental Health (NIMH). (December, 2023). Mental Health Medications. https://www.nimh.nih.gov/health/topics/mental-health-medications
National Institute of Mental Health (NIMH). (December, 2024). Anxiety Disorders. https://www.nimh.nih.gov/health/topics/anxiety-disorders
MedlinePlus. (March 15, 2026). Metoprolol. U.S. National Library of Medicine. https://medlineplus.gov/druginfo/meds/a682864
